We are live on
!
Find out more
Vanguard Portfolio Management Portfolio holdings
AUM
$2.22T
This Fund
S&P 500
This Quarter
Est. Return
+25.71%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.22T
AUM Growth
+$305B
(+16%)
Cap. Flow
+$19.5B
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
21.57%
Holding
3,286
New
192
Increased
2,077
Reduced
864
Closed
145
Avg Time Held
0.9
quarters
Top 10 Avg Time Held
0.8
quarters
Top 20 Avg Time Held
0.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$1.74B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$1.66B |
| 3 |
NVIDIA
NVDA
|
+$1.58B |
| 4 |
Micron Technology
MU
|
+$1.23B |
| 5 |
Devon Energy
DVN
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$2.45B |
| 2 |
Seagate
STX
|
+$2.36B |
| 3 |
Western Digital
WDC
|
+$1.98B |
| 4 |
Honeywell
HON
|
+$1.74B |
| 5 |
Corning
GLW
|
+$1.7B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.19% |
| 2 | Financials | 11.67% |
| 3 | Industrials | 11.45% |
| 4 | Healthcare | 9.73% |
| 5 | Consumer Discretionary | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2126
Heartland Express
HTLD
$860M
| $12.5M | ﹤0.01% |
819,448
+7,804
| +1% | +$106K |
2026 Q1
1 quarter
|
|
|
BCAX
2127
Bicara Therapeutics
BCAX
$1.16B
| $12.4M | ﹤0.01% |
418,912
+127,973
| +44% | +$2.86M |
2026 Q1
1 quarter
|
|
2128
Orrstown Financial Services
ORRF
$804M
| $12.4M | ﹤0.01% |
304,510
+44,558
| +17% | +$1.68M |
2026 Q1
1 quarter
|
|
2129
PubMatic
PUBM
$849M
| $12.4M | ﹤0.01% |
947,548
+308,763
| +48% | +$3.21M |
2026 Q1
1 quarter
|
|
2130
GFL Environmental
GFL
$18.7B
| $12.4M | ﹤0.01% |
+337,230
| New | +$12.7M |
2026 Q2
0 quarters
|
|
2131
Community Trust Bancorp
CTBI
$1.35B
| $12.4M | ﹤0.01% |
171,207
+25,475
| +17% | +$1.7M |
2026 Q1
1 quarter
|
|
2132
Metropolitan Bank Holding Corp
MCB
$1.07B
| $12.3M | ﹤0.01% |
124,836
+23,292
| +23% | +$2.11M |
2026 Q1
1 quarter
|
|
2133
Fate Therapeutics
FATE
$261M
| $12.3M | ﹤0.01% |
4,545,893
+411,308
| +10% | +$761K |
2026 Q1
1 quarter
|
|
2134
Wave Life Sciences
WVE
$682M
| $12.3M | ﹤0.01% |
2,110,751
+934,544
| +79% | +$6.2M |
2026 Q1
1 quarter
|
|
2135
Grid Dynamics Holdings
GDYN
$645M
| $12.2M | ﹤0.01% |
2,153,933
-626,020
| -23% | -$3.87M |
2026 Q1
1 quarter
|
|
2136
Liberty Latin America Class C
LILAK
$1.59B
| $12.2M | ﹤0.01% |
1,563,232
-139,161
| -8% | -$1.01M |
2026 Q1
1 quarter
|
|
2137
Corvus Pharmaceuticals
CRVS
$885M
| $12.2M | ﹤0.01% |
814,750
+144,855
| +22% | +$2.01M |
2026 Q1
1 quarter
|
|
2138
CRA International
CRAI
$1.11B
| $12.1M | ﹤0.01% |
85,291
-9,109
| -10% | -$1.37M |
2026 Q1
1 quarter
|
|
2139
Ivanhoe Electric
IE
$1.63B
| $12.1M | ﹤0.01% |
1,257,268
+299,838
| +31% | +$3.79M |
2026 Q1
1 quarter
|
|
|
ALM
2140
Almonty Industries
ALM
$3.42B
| $12.1M | ﹤0.01% |
+729,468
| New | +$13.9M |
2026 Q2
0 quarters
|
|
2141
Mission Produce
AVO
$1.03B
| $12M | ﹤0.01% |
1,021,951
+239,551
| +31% | +$3.03M |
2026 Q1
1 quarter
|
|
2142
iRadimed
IRMD
$1.12B
| $12M | ﹤0.01% |
125,357
+2,932
| +2% | +$267K |
2026 Q1
1 quarter
|
|
2143
Aveanna Healthcare
AVAH
$2.67B
| $11.9M | ﹤0.01% |
1,393,499
+170,450
| +14% | +$1.2M |
2026 Q1
1 quarter
|
|
|
BKV
2144
BKV Corp
BKV
$2.65B
| $11.9M | ﹤0.01% |
436,111
+53,215
| +14% | +$1.46M |
2026 Q1
1 quarter
|
|
|
ORC
2145
Orchid Island Capital
ORC
$1B
| $11.9M | ﹤0.01% |
1,709,184
+330,446
| +24% | +$2.28M |
2026 Q1
1 quarter
|
|
2146
Southern Missouri Bancorp
SMBC
$770M
| $11.8M | ﹤0.01% |
155,405
+11,282
| +8% | +$779K |
2026 Q1
1 quarter
|
|
|
MH
2147
McGraw Hill
MH
$2.56B
| $11.8M | ﹤0.01% |
1,244,483
-75,331
| -6% | -$908K |
2026 Q1
1 quarter
|
|
|
MAZE
2148
Maze Therapeutics
MAZE
$1.51B
| $11.7M | ﹤0.01% |
393,107
+197,565
| +101% | +$5.18M |
2026 Q1
1 quarter
|
|
2149
Wabash National
WNC
$538M
| $11.7M | ﹤0.01% |
868,608
+3,834
| +0.4% | +$34.1K |
2026 Q1
1 quarter
|
|
2150
Editas Medicine
EDIT
$445M
| $11.7M | ﹤0.01% |
3,598,339
+449,769
| +14% | +$1.31M |
2026 Q1
1 quarter
|
|
Similar funds
Vanguard Portfolio Management's Q2 2026 Portfolio in Review
As of Q2 2026, Vanguard Portfolio Management held 3,286 positions worth $2.22T, up 16% from $1.91T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Vanguard Portfolio Management's Q2 2026 filing shows 192 new, 2,077 increased, 864 reduced and 145 closed positions. Its largest new stake was SpaceX: 10,225,389 shares worth $1.75B. The largest sale was Marvell Technology, an estimated $2.45B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 29% a quarter earlier, followed by Financials and Industrials.
- Vanguard Portfolio Management's largest Q2 2026 buy was SpaceX: 10,225,389 shares worth $1.75B.
- Vanguard Portfolio Management added most to NVIDIA in Q2 2026, an estimated $1.58B increase.
- Vanguard Portfolio Management's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $2.45B.
- Vanguard Portfolio Management fully exited Coterra Energy in Q2 2026, selling an estimated $1.3B.
- Vanguard Portfolio Management's ten largest holdings make up 22% of its $2.22T portfolio in Q2 2026.
- Vanguard Portfolio Management opened 192 new positions and closed 145 in Q2 2026.
- Vanguard Portfolio Management's portfolio value rose 16% quarter-over-quarter to $2.22T.
Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.